LORLATINIB for Small cell lung cancer: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

There are 10 adverse event reports in the FDA FAERS database where LORLATINIB was used for Small cell lung cancer.

Most Reported Side Effects for LORLATINIB

Side Effect	Reports	%	Deaths	Hosp.
Death	1,050	19.1%	1,047	74
Neoplasm progression	633	11.5%	278	155
Off label use	394	7.2%	97	87
Weight increased	306	5.6%	17	46
Hallucination	290	5.3%	21	56
Blood cholesterol increased	281	5.1%	32	47
Dyspnoea	223	4.1%	49	113
Oedema peripheral	198	3.6%	29	62
Oedema	195	3.5%	17	36
Fatigue	188	3.4%	44	49
Peripheral swelling	164	3.0%	21	30
Cognitive disorder	158	2.9%	11	31
Hypercholesterolaemia	157	2.9%	19	43
Blood triglycerides increased	145	2.6%	19	35
Neuropathy peripheral	142	2.6%	3	17